Notably, while traditional biomarkers such as AFP, GPC3, and TP53 [31] primarily influence tumor growth, differentiation, proliferation, and genomic stability, our model genes exhibit distinct functional relevance to lipid metabolism pathways in HCC. The gene discussed is TP53; the disease is hepatocellular carcinoma.